Citadel Advisors »

Seelos Therapeutics Ord shares owned by Citadel Advisors

Quarter-by-quarter ownership of Seelos Therapeutics Ord (SEEL) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Seelos Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Ord held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Ord by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $63k 45k 1.39

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Seelos Therapeutics Ord

Wealth Effects
Vanguard Group
Balyasny Asset Management
Jeffrey L. Gendell
Modera Wealth Management
Citadel Advisors
Lynwood Capital Management
Strategic Family Wealth Counselors
Two Sigma Investments
CRA Financial Services
Wealth Enhancement Advisory Services
Advisor Group Holdings
Carmichael Hill & Associates
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Seelos Therapeutics Ord